STERIS Net Change in Intangible Assets 2010-2025 | STE
STERIS annual/quarterly net change in intangible assets history and growth rate from 2010 to 2025. Net change in intangible assets can be defined as the overall change from the sale and purchase of intangible assets including patents, rights and capitalized software.
- STERIS net change in intangible assets for the quarter ending March 31, 2025 was $0M, a 0% increase year-over-year.
- STERIS net change in intangible assets for the twelve months ending March 31, 2025 was $0M, a 0% increase year-over-year.
- STERIS annual net change in intangible assets for 2024 was $0B, a 0% decline from 2023.
- STERIS annual net change in intangible assets for 2023 was $0B, a 0% decline from 2022.
- STERIS annual net change in intangible assets for 2022 was $0B, a 0% decline from 2021.
| STERIS Annual Net Change in Intangible Assets (Millions of US $) |
|
|---|---|
| 2024 | $N/A |
| 2023 | $N/A |
| 2022 | $N/A |
| 2021 | $N/A |
| 2020 | $N/A |
| 2019 | $N/A |
| 2018 | $N/A |
| 2017 | $N/A |
| 2016 | $N/A |
| 2015 | $N/A |
| 2014 | $N/A |
| 2013 | $N/A |
| 2012 | $N/A |
| 2011 | $N/A |
| 2010 | $N/A |
| 2009 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $22.352B | $5.460B |
| STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $202.843B | 88.85 |
| Thermo Fisher Scientific (TMO) | United States | $153.281B | 18.54 |
| Edwards Lifesciences (EW) | United States | $45.022B | 29.52 |
| Alcon (ALC) | Switzerland | $43.031B | 29.08 |
| IDEXX Laboratories (IDXX) | United States | $40.969B | 47.08 |
| DexCom (DXCM) | United States | $33.925B | 52.44 |
| IQVIA Holdings (IQV) | United States | $24.535B | 13.74 |
| Mettler-Toledo (MTD) | United States | $23.231B | 27.63 |
| Waters (WAT) | United States | $20.553B | 29.00 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.219B | 0.00 |
| Hologic (HOLX) | United States | $12.337B | 13.40 |
| Penumbra (PEN) | United States | $11.191B | 87.83 |
| Sysmex ADR (SSMXY) | Japan | $10.965B | 31.11 |
| Masimo (MASI) | United States | $8.304B | 30.63 |
| Globus Medical (GMED) | United States | $8.001B | 18.76 |
| Teleflex (TFX) | United States | $5.535B | 9.14 |
| Glaukos (GKOS) | United States | $5.232B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.173B | 21.87 |
| TransMedics (TMDX) | United States | $4.139B | 89.97 |
| PROCEPT BioRobotics (PRCT) | United States | $3.030B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.375B | 14.14 |
| Veracyte (VCYT) | United States | $2.231B | 31.31 |
| Nihon Kohden (NHNKY) | Japan | $2.050B | 23.51 |
| Elekta AB (EKTAY) | Sweden | $2.021B | 18.17 |
| Alphatec Holdings (ATEC) | United States | $1.862B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.522B | 0.00 |
| Artivion (AORT) | United States | $1.238B | 115.92 |
| Pulse Biosciences (PLSE) | United States | $1.097B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.004B | 5.34 |
| OPKO Health (OPK) | United States | $0.999B | 0.00 |
| SiBone (SIBN) | United States | $0.799B | 0.00 |
| IRadimed (IRMD) | United States | $0.660B | 33.49 |
| Mesa Laboratories (MLAB) | United States | $0.653B | 14.26 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.562B | 8.74 |
| Beta Bionics (BBNX) | United States | $0.557B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.555B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.539B | 0.00 |
| AxoGen (AXGN) | United States | $0.538B | 0.00 |
| RxSight (RXST) | United States | $0.538B | 0.00 |
| NeuroPace (NPCE) | United States | $0.512B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.467B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.423B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.377B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.363B | 9.66 |
| ClearPoint Neuro (CLPT) | United States | $0.348B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.330B | 0.00 |
| Neuronetics (STIM) | United States | $0.283B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.223B | 13.49 |
| Alpha Tau Medical (DRTS) | Israel | $0.199B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.170B | 0.00 |
| LENSAR (LNSR) | United States | $0.167B | 0.00 |
| Accuray (ARAY) | United States | $0.164B | 0.00 |
| Inogen (INGN) | United States | $0.158B | 0.00 |
| 908 Devices (MASS) | United States | $0.155B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.148B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.139B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.138B | 0.00 |
| CVRx (CVRX) | United States | $0.138B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.133B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.130B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.088B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.085B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.080B | 12.05 |
| InspireMD (NSPR) | Israel | $0.072B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.066B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.064B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.057B | 0.00 |
| Hyperfine (HYPR) | United States | $0.048B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.91 |